Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of Apararenone in Diabetic Nephropathy
NCT01889277Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Jul 2013
- Primary completion
- Jan 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of apararenone in diabetic nephropathy (DN), sponsored by Mitsubishi Tanabe Pharma Corporation. Started Jul 2013; status: completed.
02
Drugs
apararenone
03
Conditions
diabetic nephropathy (DN)
Beyond the preview
Go deeper on NCT01889277.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01889277.